Clay Siegall Makes His Mark as a Health Expert
Clay Siegall is a biotechnologist who works at Seattle Genetics as the CEO. He also has a blog on WordPress where he uses it as a platform to inform the world on the progress made in the world of biotechnology. For instance, in one of his recent posts, he talks about an important discovery made by scientists linking Alzheimer’s disease to immunity of the brain. In the research report, scientists have realized that the once thought to be harmful amyloid-beta plaques which cause the disease are key players in the brain’s immune system. They are good for the brain but only cause harm when produced in large amounts.
In another post, Siegall shares his concern about world safety due to the research being conducted by scientists using horsepox made in the lab to come up with better vaccines for smallpox. The process has raised major concern among different people since making of the horsepox in the lab reveals the recipe of its manufacture and thus putting the world at risk if used as a bioweapon.
About Clay Siegall
Clay Siegall is the co-founder, CEO, President, and Chairman of the Board of Directors of Seattle Genetics a company that deals with cancer-related research and manufacturing drugs used in cancer treatment. He is also a member of Alder BioPharmaceuticals and has worked in the National Cancer Institute and the National Institute of Health. Clay has a degree in Zoology from the University of Maryland and a Ph.D. in Genetics from Washington University.
Under Siegall’s leadership, Seattle Genetics has gained global recognition for its dedication in the fight against cancer. It has focused on cancer research developments and taken part in the making of cancer-fighting drugs and cancer therapies like the ADCRETIS. As the company’s CEO, he has also helped raise capital for the company which has helped in funding research activities and drug development processes. Clay Siegall has played a major role in cancer research due to his commitment to helping people with cancer.